Cellectis S.A. CLLS
$ 1.58
-0.94%
Annual report 2023
added 12-21-2024
Country |
France |
IPO year |
2015 |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBAL |
CEO |
Dr. Andr Choulika |
Employees in the company |
253 |
Shares |
- |
Market Cap[1] |
$ 116 M |
EBITDA (LTM) |
$ -106 M |
P/E (LTM) |
-0.88 |
P/S (LTM) |
7.72 |
EPS (LTM) |
-2.43 |
Other stocks of industry "Biotechnology"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.